• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度新德里南部一家大学教学医院中哮喘与慢性阻塞性肺疾病的可逆性、免疫球蛋白E、嗜酸性粒细胞及中性粒细胞计数相关性评估

Assessment of asthma and chronic obstructive pulmonary disorder in relation to reversibility, IgE, eosinophil, and neutrophil count in a University Teaching Hospital in South Delhi, India.

作者信息

Rathod Virender P Singh, Kapoor Prem, Pillai K K, Khanam Razia

机构信息

Department of Pharmacology, Faculty of Pharmacy, Majeedia Hospital, Jamia Hamdard University, New Delhi - 110 062, India.

出版信息

J Pharm Bioallied Sci. 2010 Oct;2(4):337-40. doi: 10.4103/0975-7406.72136.

DOI:10.4103/0975-7406.72136
PMID:21180468
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2996067/
Abstract

OBJECTIVES

The physiological and clinical similarities between asthma and chronic obstructive pulmonary disorder (COPD) make their differentiation difficult. In the present study, we compared reversibility to bronchodilator, immunoglobulin E (IgE), blood eosinophil and neutrophil levels among asthma and COPD patients to differentiate these diseases.

MATERIALS AND METHODS

The study was carried on 20 asthmatics and 29 patients of COPD that reported to the outpatient and inpatient department in University Teaching Hospital, Jamia Hamdard, New Delhi, India. The parameters evaluated included pulmonary function (FEV(1), FVC, and FEV(1)/FVC), IgE levels, and eosinophil and neutrophil count.

RESULTS

It was observed that reversibility was significantly higher in asthmatic patients, while irreversibility predominates in COPD patients. There was no significant difference in pre- and post-FEV(1) and pre- and post-FVC and in their percentage predicted. However the percentage change in FEV(1) significantly varies in asthma and COPD patients. No significant changes in neutrophil and eosinophil levels were observed in these patients. The serum IgE levels were found significantly higher in asthmatic patients.

CONCLUSIONS

We conclude that reversibility in FEV(1) levels or percentage change in FEV(1) and serum IgE levels are promising lab parameter to distinguish these two conditions. However, further research is required to fully understand the role of neutrophil and eosinophil in the onset and development of asthma and COPD.

摘要

目的

哮喘与慢性阻塞性肺疾病(COPD)在生理和临床方面存在相似之处,这使得二者难以区分。在本研究中,我们比较了哮喘患者和COPD患者对支气管扩张剂的反应性、免疫球蛋白E(IgE)、血液嗜酸性粒细胞和中性粒细胞水平,以鉴别这两种疾病。

材料与方法

该研究对印度新德里贾米亚·哈马德大学教学医院门诊和住院部的20例哮喘患者和29例COPD患者进行。评估的参数包括肺功能(第一秒用力呼气容积(FEV₁)、用力肺活量(FVC)和FEV₁/FVC)、IgE水平以及嗜酸性粒细胞和中性粒细胞计数。

结果

观察到哮喘患者的反应性显著更高,而COPD患者则以不可逆性为主。FEV₁前后、FVC前后及其预测百分比均无显著差异。然而,哮喘患者和COPD患者的FEV₁百分比变化显著不同。这些患者的中性粒细胞和嗜酸性粒细胞水平未观察到显著变化。哮喘患者的血清IgE水平显著更高。

结论

我们得出结论,FEV₁水平的反应性或FEV₁百分比变化以及血清IgE水平是区分这两种疾病的有前景的实验室参数。然而,需要进一步研究以充分了解中性粒细胞和嗜酸性粒细胞在哮喘和COPD发病及发展中的作用。

相似文献

1
Assessment of asthma and chronic obstructive pulmonary disorder in relation to reversibility, IgE, eosinophil, and neutrophil count in a University Teaching Hospital in South Delhi, India.印度新德里南部一家大学教学医院中哮喘与慢性阻塞性肺疾病的可逆性、免疫球蛋白E、嗜酸性粒细胞及中性粒细胞计数相关性评估
J Pharm Bioallied Sci. 2010 Oct;2(4):337-40. doi: 10.4103/0975-7406.72136.
2
Post-bronchodilator Reversibility of FEV and Eosinophilic Airway Inflammation in COPD.COPD 患者支气管扩张剂后 FEV 和嗜酸性气道炎症的可逆性。
Arch Bronconeumol. 2017 Oct;53(10):547-553. doi: 10.1016/j.arbres.2017.01.014. Epub 2017 Apr 21.
3
[Comparison of lung volume response with airflow response to bronchodilator in patients with chronic obstructive pulmonary disease].[慢性阻塞性肺疾病患者肺容积反应与支气管扩张剂气流反应的比较]
Zhonghua Jie He He Hu Xi Za Zhi. 2010 Feb;33(2):109-13.
4
Biomarkers for differentiation of patients with asthma and chronic obstructive pulmonary disease.用于区分哮喘和慢性阻塞性肺疾病患者的生物标志物。
J Asthma. 2018 Oct;55(10):1052-1058. doi: 10.1080/02770903.2017.1391281. Epub 2017 Dec 1.
5
The impact of inflammatory cells on lung function in asthmatics in a cross sectional retrospect study.一项横断面回顾性研究中炎症细胞对哮喘患者肺功能的影响。
Heliyon. 2024 Jun 28;10(13):e33691. doi: 10.1016/j.heliyon.2024.e33691. eCollection 2024 Jul 15.
6
[Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].[哮喘和慢性阻塞性肺疾病患者诱导痰中金属蛋白酶-9/金属蛋白酶组织抑制剂-1及其与气道炎症和气流受限的关系]
Zhonghua Jie He He Hu Xi Za Zhi. 2007 Mar;30(3):192-6.
7
Computed tomographic scan-diagnosed chronic obstructive pulmonary disease-emphysema: eotaxin-1 is associated with bronchodilator response and extent of emphysema.计算机断层扫描诊断的慢性阻塞性肺疾病-肺气肿:嗜酸性粒细胞趋化因子-1与支气管扩张剂反应及肺气肿程度相关。
J Allergy Clin Immunol. 2007 Nov;120(5):1118-25. doi: 10.1016/j.jaci.2007.08.045.
8
[Levels of HMGB1 in induced sputum from patients with asthma and chronic obstructive pulmonary disease].[哮喘和慢性阻塞性肺疾病患者诱导痰中高迁移率族蛋白B1水平]
Zhonghua Yi Xue Za Zhi. 2011 Nov 15;91(42):2981-4.
9
[Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].[采用层次聚类分析和两步聚类分析对症状性慢性气道疾病临床表型的研究]
Zhonghua Nei Ke Za Zhi. 2016 Sep 1;55(9):679-83. doi: 10.3760/cma.j.issn.0578-1426.2016.09.005.
10
Reversibility to a beta2-agonist in COPD: relationship to atopy and neutrophil activation.慢性阻塞性肺疾病中对β2受体激动剂的反应可逆性:与特应性和中性粒细胞活化的关系
Respir Med. 2003 Jun;97(6):591-8. doi: 10.1053/rmed.2003.1485.

引用本文的文献

1
The COPD (Chronic Obstructive Pulmonary Disease) Assessment Test: Assessment of Therapeutic Outcomes of Patients at Private Hospitals in Yogyakarta.慢性阻塞性肺疾病(COPD)评估测试:日惹私立医院患者治疗结果评估
J Pharm Bioallied Sci. 2020 Nov;12(Suppl 2):S821-S825. doi: 10.4103/jpbs.JPBS_302_19. Epub 2020 Nov 5.
2
Protective association of TIM1-1454G>a polymorphism with asthma in a North Indian population.TIM1-1454G>a 多态性与北印度人群哮喘的保护相关性。
Lung. 2015 Feb;193(1):31-8. doi: 10.1007/s00408-014-9653-y. Epub 2014 Oct 21.
3
Assessment of asthma and chronic obstructive pulmonary disorder.哮喘与慢性阻塞性肺疾病的评估
J Pharm Bioallied Sci. 2011 Apr;3(2):316. doi: 10.4103/0975-7406.80758.

本文引用的文献

1
Serum interleukin-1beta as a marker for differentiation of asthma and chronic obstructive pulmonary disease.血清白细胞介素-1β作为哮喘和慢性阻塞性肺疾病鉴别的标志物。
Biomarkers. 2008 Nov;13(7):713-27. doi: 10.1080/13547500802655367.
2
Emergence of chronic obstructive pulmonary disease as an epidemic in India.慢性阻塞性肺疾病在印度成为一种流行病。
Indian J Med Res. 2006 Dec;124(6):619-30.
3
Patterns of inflammation and the use of reversibility testing in smokers with airway complaints.有气道症状的吸烟者的炎症模式及可逆性测试的应用
BMC Pulm Med. 2006 Jun 1;6:11. doi: 10.1186/1471-2466-6-11.
4
Differences between asthma and COPD in the elderly.
J Investig Allergol Clin Immunol. 2006;16(1):44-50.
5
Traditional and patient-centred outcomes with three classes of asthma medication.三类哮喘药物的传统及以患者为中心的治疗结果
Eur Respir J. 2005 Jul;26(1):36-44. doi: 10.1183/09031936.05.00144704.
6
The global burden of asthma: executive summary of the GINA Dissemination Committee report.哮喘的全球负担:全球哮喘防治创议传播委员会报告执行摘要
Allergy. 2004 May;59(5):469-78. doi: 10.1111/j.1398-9995.2004.00526.x.
7
Pharmacology of airway inflammation in asthma and COPD.哮喘和慢性阻塞性肺疾病中气道炎症的药理学
Pulm Pharmacol Ther. 2003;16(5):247-77. doi: 10.1016/S1094-5539(03)00070-1.
8
Reversibility to a beta2-agonist in COPD: relationship to atopy and neutrophil activation.慢性阻塞性肺疾病中对β2受体激动剂的反应可逆性:与特应性和中性粒细胞活化的关系
Respir Med. 2003 Jun;97(6):591-8. doi: 10.1053/rmed.2003.1485.
9
Cytokines in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中的细胞因子
Eur Respir J Suppl. 2001 Dec;34:50s-59s.
10
Asthma. From bronchoconstriction to airways inflammation and remodeling.哮喘。从支气管收缩到气道炎症与重塑。
Am J Respir Crit Care Med. 2000 May;161(5):1720-45. doi: 10.1164/ajrccm.161.5.9903102.